Skip Navigation

tag | Johnson & Johnson


Native American tribes reach $590 million opioid settlement

All federally recognized tribes in the U.S. will be able to participate in the settlements, even if they did not sue over opioids.

By The Associated Press

Mix or match: What do I need to know about vaccine boosters?

Boosters are available to a much broader range of individuals, and that the types of vaccines people can get are more diverse.

By Zoë Read/WHYY

An FDA panel of experts backs J&J COVID vaccine booster

A panel of experts voted to recommend that the Food and Drug Administration authorize a booster dose of the Johnson & Johnson COVID vaccine at least two months after the first shot.

By NPR

Support for WITF is provided by:

Become a WITF sponsor today »


For people who got the J&J vaccine, some doctors are advising boosters ASAP

Boosters are available for higher-risk people who got the Pfizer vaccine. But what about people who got the one-shot Johnson & Johnson? Some doctors say they need an extra shot even more urgently.

By NPR

Johnson & Johnson says its booster shot provides increased protection from COVID-19

Johnson & Johnson shared data from its Phase 3 trial of the company’s booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.

By NPR


State attorneys general reach a $26 billion national opioid settlement

The ultimate amount of payouts by the companies will hinge on how many governments agree to suspend their opioid lawsuits.

By NPR

US opioid lawsuits on verge of settlements with 4 companies

Under the deal, Johnson & Johnson would not produce any opioids for at least a decade.

By The Associated Press

Johnson & Johnson vaccine is linked to neurological disorder in extremely rare cases

Of the more than 12 million vaccine doses administered in the U.S., there have been around 100 reports of people developing Guillain-Barré Syndrome.

By NPR

J & J agrees to pay $230M in New York opioid settlement

Johnson & Johnson has agreed to pay $230 million to New York state to settle claims that the pharmaceutical giant helped fuel the opioid crisis…..

By The Associated Press
LOAD MORE